Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness..
J Clin Hypertens (Greenwich). 16(7), 475-6.
(2014). Renin inhibition in patients with chronic kidney disease: is it conclusively non-indicated?.
J Renin Angiotensin Aldosterone Syst. 15(1), 97-8.
(2014). Renal-limited 'lupus-like' nephritis..
Nephrol Dial Transplant. 27(6), 2337-42.
(2012). Renal sympathetic denervation: the jury is still out..
Lancet. 376(9756), 1878-80.
(2010). Renal sympathetic denervation: renal function concerns..
Hypertension. 58(4), e19; author reply e20.
(2011). Renal sympathetic denervation in hypertension..
Curr Opin Nephrol Hypertens. 20(6), 647-53.
(2011). Renal Sympathetic Denervation: Hibernation or Resurrection?.
Cardiology. 135(2), 87-97.
(2016). Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension..
Int J Hypertens. 2011, 196518.
(2011). Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?.
J Clin Hypertens (Greenwich). 20(4), 634-636.
(2018). Renal sympathetic denervation and systemic hypertension..
Am J Cardiol. 105(4), 570-6.
(2010). Renal resistive index for renovascular hypertension: In the quest of the Holy Grail..
J Clin Hypertens (Greenwich). 20(3), 589-591.
(2018). Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions..
Front Pediatr. 8, 366.
(2020). Renal physiology in elderly persons with severe immobility syndrome..
Int Urol Nephrol. 41(2), 437-41.
(2009). Renal parenchymal thickness in children measured by computed tomography..
Eur Urol. 25(1), 51-4.
(1994). Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy..
Am J Hematol. 92(7), 632-639.
(2017). Renal nerve ablation for resistant hypertension: the dust has not yet settled..
J Clin Hypertens (Greenwich). 16(6), 399-400.
(2014). Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions..
Circulation. 129(13), 1440-51.
(2014). Renal nerve ablation for hypertensive patients with chronic kidney disease..
Curr Vasc Pharmacol. 12(1), 47-54.
(2014). Renal injury progression in autosomal dominant polycystic kidney disease: a look beyond the cysts..
Nephrol Dial Transplant. 33(11), 1887-1895.
(2018). Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain..
Liver Transpl. 22(1), 132-3.
(2016). The renal endothelium in diabetic nephropathy..
Ren Fail. 35(4), 592-9.
(2013). Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox..
Acta Haematol. 123(3), 148-52.
(2010). Renal dysfunction after endovascular abdominal aortic aneurysm repair: time to use the correct outcome measures..
Kidney Int. 88(5), 1199.
(2015). Renal denervation: transition from pathophysiology to clinical practice..
Angiology. 65(9), 760-8.
(2014). Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work?.
Curr Treat Options Cardiovasc Med. 19(5), 39.
(2017).